Tci Wealth Advisors, Inc. Corbus Pharmaceuticals Holdings, Inc. Transaction History

Tci Wealth Advisors, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 21, 2021	SELL	$0.94 - $1.89 $94 - $189	-100 Closed	0 $0
Q3 2019 Oct 17, 2019	SELL	$4.87 - $7.08 $355 - $516	-73 Reduced 42.2%	100 $0
Q2 2019 Jul 23, 2019	BUY	$6.6 - $7.8 $481 - $569	73 Added 73.0%	173 $1,000
Q3 2018 Nov 02, 2018	SELL	$4.65 - $7.95 $1,860 - $3,180	-400 Reduced 80.0%	100 $1,000
Q2 2018 Jul 27, 2018	SELL	$5.05 - $6.8 $505 - $680	-100 Reduced 16.67%	500 $3,000
Q1 2018 Apr 30, 2018	BUY	$5.6 - $9.25 $560 - $925	100 Added 20.0%	600 $4,000
Q3 2017 Oct 24, 2017	SELL	$5.75 - $7.75 $575 - $775	-100 Reduced 16.67%	500 $4,000
Q2 2017 Aug 10, 2017	BUY	N/A	600	600 $4,000

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $1.27B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.